A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

Best Answer for Cancer Foundation

Overview

The IPTLD QoL Broad Study.

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer.

Study Type

OBSERVATIONAL

Conditions

Cancer

Interventions

IPTLD and nutrition therapyOTHER

The measurement of Quality of Life in patients who choose to use Insulin Potentiation Low Dose Therapy and Nutritional Therapy in the treatment of cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of cancer, * age older than 18 years, * requesting IPTLD and nutrition therapy Exclusion Criteria: * diagnosis other than cancer, * age younger than 18 years, * requesting conventional chemotherapy

Locations (1)

Arizona Center for Advanced Medicine

Scottsdale, Arizona, United States

Outcomes

Primary Outcomes

Improvement in Quality of Life measured by questionnaires

Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.